MENU
TSHA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Taysha Gene Therapies (TSHA) Ownership - Who owns Taysha Gene Therapies?
Profile
Industry
N/A
Address
3000 Pegasus Park Drive
Phone
+1 214 612-0000
Employees
52
Web
https://www.tayshagtx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
416.03M
P/E Ratio
3.22
Total Cash
157.69M
Projected Growth
N/A
Total Debt
62.54M
Revenue
9.92M
Risk (Beta)
0.37
Dividend Yield
N/A
Total Cash/Share
0.77
Total Debt/Equity
N/A
Revenue/Share
0.04 USD as % of share price
Fundamentals
TSHA
Capitalization
416M
P/E Ratio
3.22
Risk (Beta)
0.37
Dividend Yield
N/A
Total Cash
158M
Total Cash/Share
0.77
Total Debt
62.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.04%
Revenue
9.92M
ROE
N/A
Book Value
88.8M
P/B Ratio
4.69
Cash Flow
N/A
Earnings
0.63
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2K
Current Ratio
5.51
Current Revenue Per Employee
34384.62
Dividends Per Share - Security
N/A
EBITDA
-20.67M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-12.11
Shares Held By Institutions
459M
Shares Outstanding - Current
205M
Total Liabilities
91.4M
Total Volume MTD
N/A
Value
N/A
Gain YTD
14.689
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
3000 Pegasus Park Drive
Phone
+1 214 612-0000
Employees
52
Web
https://www.tayshagtx.com